High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (Q46817222)
Jump to navigation
Jump to search
scientific article published in January 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation |
scientific article published in January 2008 |
Statements
1 reference
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (English)
1 reference
Anthony Goldstone
1 reference
Charalampia Kyriakou
1 reference
Carmen Canals
1 reference
Dolores Caballero
1 reference
Bernd Metzner
1 reference
Guido Kobbe
1 reference
Hans-Jochem Kolb
1 reference
Joachim Kienast
1 reference
Peter Reimer
1 reference
Jurgen Finke
1 reference
Gunnar Oberg
1 reference
Ann Hunter
1 reference
Niklas Theorin
1 reference
Anna Sureda
1 reference
Norbert Schmitz
1 reference
Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
1 reference
1 January 2008
1 reference
26
1 reference
2
1 reference
218-224
1 reference